Home 禄 Business 禄 Manufacturing
Medicinal boost
By Ding Yining |
May 8, 2010, Saturday
|
Print Edition
Print Edition
BOEHRINGER Ingelheim expects its sales in China to grow about 45 percent to 1.76 billion yuan (US$257 million) this year as it expands its product portfolio and a boom in demand in China's rural areas.
The German drug maker's global sales last year rose 9.7 percent to 12.7 billion euros (US$16.2 billion).
"China is expected to contribute about 15 percent to our global sales growth this year and will account for around 50 percent of growth in emerging markets around the globe," said David Preston, general manager of Boehringer Ingelheim Shanghai Pharmaceuticals Co. "We're also actively in talks with several local companies for merger and acquisition deals to increase our over-the-counter products and even traditional Chinese medicine."
The company is also planning to introduce six innovative drugs to treat oncology and diabetes during 2013 and 2015.
The German drug maker's global sales last year rose 9.7 percent to 12.7 billion euros (US$16.2 billion).
"China is expected to contribute about 15 percent to our global sales growth this year and will account for around 50 percent of growth in emerging markets around the globe," said David Preston, general manager of Boehringer Ingelheim Shanghai Pharmaceuticals Co. "We're also actively in talks with several local companies for merger and acquisition deals to increase our over-the-counter products and even traditional Chinese medicine."
The company is also planning to introduce six innovative drugs to treat oncology and diabetes during 2013 and 2015.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
